Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SE & CO. KGAA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical SE & Co. KGaA adopts resolution on share buy-back program for up to 500,000 treasury shares

11/25/2021 | 02:58pm EST

DGAP-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Share Buyback
CompuGroup Medical SE & Co. KGaA adopts resolution on share buy-back program for up to 500,000 treasury shares

25-Nov-2021 / 20:56 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


The general partner of CompuGroup Medical SE & Co. KGaA (the "Company") (ISIN: DE000A288904 | WKN: A28890), utilising the authorization granted by its annual general meeting of May 19, 2021 and pursuant to section 71(1) no. 8 of the German Stock Corporation Act (Aktiengesetz), resolved today to buy back a maximum number of up to 500,000 shares of the Company (corresponding to approx. 0.93% of the Company's share capital) at a maximum purchase price (excluding transaction costs) of up to EUR 37,000,000.00 in total (the "Share Buy-back Program").

The Share Buy-back Program will be carried out by a credit institution. The credit institution will acquire the shares on the stock market and will decide on the timing of acquisition independently of the Company in accordance with the safe harbor provisions of Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (Market Abuse Regulation) in conjunction with the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016. In addition, the consideration paid per share (excluding transaction costs) must not exceed, or fall short of, the price of the Company's shares in XETRA (or a comparable successor system) trading on the Frankfurt Stock Exchange determined by the opening auction on the trading day by more than 10%.

Shares will be bought back in the period from November 26, 2021 to and including January 27, 2022. The Company's treasury shares acquired by means of the Share Buy-back Program may be used for any purpose permitted under the authorization granted by the annual general meeting of May 19, 2021.

Further details will be published separately by the Company prior to the start of the share buy-back.


25-Nov-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 7030
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1252102

 
End of Announcement DGAP News Service

1252102  25-Nov-2021 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1252102&application_name=news&site_id=zonebourse_sftp

ę EQS 2021
All news about COMPUGROUP MEDICAL SE & CO. KGAA
01/20COMPUGROUP MEDICAL SE & CO. KGAA : Notification and public disclosure of transactions by p..
EQ
01/19COMPUGROUP MEDICAL : Berenberg reaffirms its Buy rating
MD
01/18COMPUGROUP MEDICAL : Buy rating from Baader Bank
MD
01/18CompuGroup Medical expects continued strong organic growth in 2022 and first step towar..
EQ
01/18CompuGroup Medical SE & Co. KGaA Announces Delay in Publication of the Preliminary Resu..
CI
01/18CompuGroup Medical SE & Co. KGaA Provides Revenue Guidance for the Fiscal Year 2021 and..
CI
01/14COMPUGROUP MEDICAL : Kepler Cheuvreux gives a Buy rating
MD
01/11COMPUGROUP MEDICAL : Raised from Sell to Buy by Baader Bank
MD
01/10COMPUGROUP MEDICAL SE & CO. KGAA : Share Buy-Back Program - 6th Interim Announcement, conc..
EQ
01/03COMPUGROUP MEDICAL SE & CO. KGAA : Share Buy-Back Program - 5th Interim Announcement
EQ
More news
Analyst Recommendations on COMPUGROUP MEDICAL SE & CO. KGAA
More recommendations
Financials
Sales 2021 1 022 M 1 139 M 1 139 M
Net income 2021 79,2 M 88,3 M 88,3 M
Net Debt 2021 535 M 596 M 596 M
P/E ratio 2021 38,7x
Yield 2021 0,88%
Capitalization 3 014 M 3 364 M 3 360 M
EV / Sales 2021 3,47x
EV / Sales 2022 3,20x
Nbr of Employees 8 079
Free-Float 48,8%
Chart COMPUGROUP MEDICAL SE & CO. KGAA
Duration : Period :
CompuGroup Medical SE & Co. KGaA Technical Analysis Chart | COP | DE000A288904 | MarketScreener
Technical analysis trends COMPUGROUP MEDICAL SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 57,25 €
Average target price 84,25 €
Spread / Average Target 47,2%
EPS Revisions
Managers and Directors
Dirk W÷ssner Chairman-Management Board & CEO
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Sven Thomas MŘller Chief Information Officer
Ulrike Handel Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
COMPUGROUP MEDICAL SE & CO. KGAA-19.54%3 367
ORACLE CORPORATION-7.72%213 048
SAP SE-13.39%145 806
SERVICENOW, INC.-13.56%105 207
CONSTELLATION SOFTWARE INC.-13.60%33 797
DOCUSIGN, INC.-22.99%21 903